Necrotizing Pancreatitis Infected with Stenotrophomonas maltophilia: An Emerging Rare Multidrug-Resistant Organism

Sophia Dar1, Nooraldin Merza2, Maryam Haider3

  • 1Department of Internal Medicine, Hackensack University Medical Center, Hackensack, NJ, USA.

Insights

Stenotrophomonas maltophilia, a multidrug-resistant pathogen, can complicate necrotizing pancreatitis. Trimethoprim-sulfamethoxazole is the recommended treatment for this rare but critical infection.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Critical Care Medicine

Background:

  • Stenotrophomonas maltophilia (SM) is a multidrug-resistant Gram-negative bacillus.
  • SM is an emerging nosocomial and environmental pathogen.
  • It exhibits intrinsic resistance to carbapenems, a common treatment for necrotizing pancreatitis (NP).